J&J Spends $800M to Settle Most Risperdal Lawsuits

Johnson & Johnson said it has settled most of the lawsuits it faced by thousands of men who claimed its anti-psychotic drug Risperdal caused them to develop excessive breast tissue and disclosed that it recorded $800 million in expenses in …

from News – Insurance Journal https://ift.tt/2ZJTp5C
via IFTTT